MR
Manju Rani
About Manju Rani
Data last updated:
Manju Rani has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Aurista Pharma Private Limited and Aurista Parenterals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Aurista Pharma Private Limited at ₹1.35 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aurista Pharma Private Limited U24239UR2021PTC012510 | Director | 11 Jun 2021 | 2021 | ₹1.35 Cr (FY 2025) | Active |
| Aurista Parenterals Private Limited U24230UR2023PTC015208 | Director | 17 Jan 2023 | 2023 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manju Rani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manju Rani
Manju Rani has 5 years in corporate governance. Holds Director role. Currently with 2 companies, including Aurista Pharma Private Limited and Aurista Parenterals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Aurista Pharma Private Limited at ₹1.35 Cr (FY 2025).
Manju Rani is associated with 2 companies as Director, including Aurista Pharma Private Limited (₹1.35 Cr), Aurista Parenterals Private Limited.
Manju Rani has expertise in General Business.
Manju Rani has 5 years in corporate governance.
By reported revenue, the largest current company of Manju Rani is Aurista Pharma Private Limited, with revenue of ₹1.35 Cr (FY 2025).
Manju Rani currently holds positions at 2 companies: Aurista Pharma Private Limited (₹1.35 Cr), Aurista Parenterals Private Limited.